2020
DOI: 10.1111/php.13264
|View full text |Cite
|
Sign up to set email alerts
|

Singlet Oxygen Luminescence Image in Blood Vessels During Vascular‐Targeted Photodynamic Therapy

Abstract: Singlet oxygen (1O2) is widely regarded as the main cytotoxic substance that induces the biological damage for photodynamic therapy (PDT). In this study, the previously developed near‐infrared (NIR) optical imaging system was optimized for fast imaging of 1O2 luminescence. The optical imaging system enables direct imaging of 1O2 luminescence in blood vessels within 2 s during vascular‐targeted PDT (V‐PDT), which makes this system extremely practical for in vivo studies. The dependence of RB concentration on 1O… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 22 publications
(40 reference statements)
0
4
0
Order By: Relevance
“…Singlet oxygen ( 1 O 2 ) is one of the important indexes for the efficacy of PDT. 48 It has high oxidation activity and ROS to change the spectrum of the detection agent. We selected the 1 O 2 detector ABDA.…”
Section: Methodsmentioning
confidence: 99%
“…Singlet oxygen ( 1 O 2 ) is one of the important indexes for the efficacy of PDT. 48 It has high oxidation activity and ROS to change the spectrum of the detection agent. We selected the 1 O 2 detector ABDA.…”
Section: Methodsmentioning
confidence: 99%
“…Vascular-targeted photodynamic therapy (V-PDT), which works by inducing vasculature shut-down, is a critical PDT mechanism and has become an important therapeutic method in clinical treatments of vascular-related diseases, including prostate cancer, age-related macular degeneration, and port-wine stains (PWS) [1][2] [3]. Particularly, in China, hematoporphyrin monomethyl ether (HMME)-mediated V-PDT has been proved to be an efficient therapeutic modality for PWS [4] [5].…”
Section: Introductionmentioning
confidence: 99%
“…In 1938, Kautsky proposed the energy transfer from a photosensitizer (PS) in its triplet state to molecular oxygen as the generation pathway [3], and it was not until 1968 that Snelling [4] was able to prove it. Today, there is general agreement that local generation of 1 O 2 might be one possible way to treat cancer and other diseases [1,2,[5][6][7]. All it takes is an appropriate PS, illumination at a useful wavelength, and some oxygen [8].…”
Section: Introductionmentioning
confidence: 99%